Renaissance Capital logo

Xencor Priced, Nasdaq: XNCR

Biotech developing antibodies for severe autoimmune/allergic diseases and cancer.

Industry: Health Care

First Day Return: +51.6%

Industry: Health Care

Biotech developing antibodies for severe autoimmune/allergic diseases and cancer.
more less
IPO Data
IPO File Date 10/11/2013
Offer Price $5.50
Price Range $5.50 - $5.50
Offer Shares (mm) 12.7
Deal Size ($mm) $70
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 12/02/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $70
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Monrovia, CA, United States
Founded 1997
Employees at IPO 31
Website www.xencor.com

Xencor (XNCR) Performance